Manipal Health Enterprises, Emami Group break logjam on AMRI Hospitals
Reportedly, Max Healthcare had entered the fray for AMRI Hospitals, offering a better bid than Manipal Health's Rs 1,800-crore offer for AMRI08-02-2023
08-02-2023
EMAMI LTD.-$ - 531162 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of Newspaper publications regarding the Unaudited Financial Results for the Third Quarter and Nine months ended 31st December, 2022 in Business Standard (National Daily Newspaper) & Aajkal (regional Daily Newspaper) on Saturday, 4th February, 2023.07-02-2023
EMAMI LTD.-$ - 531162 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Enclosing copy of transcript of Earnings Conference Call, post declaration of Unaudited Financial Results of the Company for the Third Quarter ended 31st December, 2022,07-02-2023
EMAMI LTD.-$ - 531162 - Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shri Harsha Vardhan Agarwal & Shri Ashish Goenka07-02-2023
EMAMI LTD.-$ - 531162 - Record Date For Ascertaining The Names Of The Members Who Will Be Entitled To Receive The 2Nd Interim Dividend For The FY 2022-23
Record date for ascertaining the names of the members who will be entitled to receive the Second Interim Dividend is Monday, 13th February, 2023.06-02-2023
Emami sees 200-300 basis points margin growth on year in March quarter
Emami reported a 6.12 per cent increase in consolidated profit after tax to 232.97 crore for the quarter ended December 202205-02-2023
Emami net profit up 7.8% at Rs 237.13 cr, says rural demand slowing
Domestic business grows one per cent in the quarter; international by 7%03-02-2023
Q3FY23 Quarterly Result Announced for Emami Ltd.
Personal products firm Emami announced Q3FY23 results: Consolidated Q3FY23: Net sales at Rs 975 crore grew by 2%; 3-year CAGR of 7%. Revenue from operations at Rs 983 crore grew by 1%; 3-year CAGR of 7%. PAT at Rs 237 crore grew by 8%; 3-year CAGR of 16%. EBIDTA at Rs 294 crore contracted by 14% due to inflationary input costs, the inclusion of new subsidiary costs, and strategic outlay on distribution expansion in rural, digital and modern trade channels; However, a 3-year CAGR of 4%. The Board of Directors declared the 2nd Interim Dividend at 400% i.e. Rs 4 per equity share. Mr Harsha V Agarwal, Vice Chairman and Managing Director, Emami Limited said: “The environment has been challenging due to high inflation, consumption slowdown, poor rural growth and a warmer winter. In the given circumstances, we have delivered satisfactory performance with a 7% revenue growth on a 3 year CAGR basis in Q3FY23. We continue to invest strongly behind our power brands, innovations, channel expansions and distribution optimizations. We believe that these sustained efforts will help us achieve sustainable and profitable growth” Mr Mohan Goenka, Vice Chairman and Whole-Time Director, Emami Limited said: “Notwithstanding the muted consumption patterns, our focus on innovation remains strong. Our new launches and digital-first NPD’s have contributed 4% to our Domestic net sales during the quarter and new age channels viz. Modern trade, eCommerce and D2C continue to grow in excess of 20%. Our International business also reported 7% quarterly growth despite tough market challenges in Bangladesh, Nepal and Sri Lanka.” Result PDF03-02-2023
EMAMI LTD.-$ - 531162 - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)
Press Release in relation to the Unaudited Financial Results of the Company for the Third Quarter and Nine Months ended 31st December, 202203-02-2023
EMAMI LTD.-$ - 531162 - Announcement under Regulation 30 (LODR)-Investor Presentation
Presentation on Company's Performance update for the quarter and nine months ended 31st December, 202203-02-2023